Research News and Research

RSS
PAMAM G-3 actually prevents activation of the process that leads to thrombosis

PAMAM G-3 actually prevents activation of the process that leads to thrombosis

Calif. Medi-Cal payments could be hurting patient access; Kansas Medicaid struggles with waiting lists for developmentally disabled

Calif. Medi-Cal payments could be hurting patient access; Kansas Medicaid struggles with waiting lists for developmentally disabled

Viewpoints: Cutting health costs is next battle; Texas Medicaid chief on why expansion won't work; Grief, anger over end-of-life decision

Viewpoints: Cutting health costs is next battle; Texas Medicaid chief on why expansion won't work; Grief, anger over end-of-life decision

Study shows disturbing rates of new HIV infections among U.S. black MSM

Study shows disturbing rates of new HIV infections among U.S. black MSM

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

FDA approves Forest Laboratories’ Tudorza Pressair to treat COPD

Roundup: Plan for new Md. hospital advances; Outsourcing of prison health care gets scrutiny; Alaska Native medical center seen as model

Roundup: Plan for new Md. hospital advances; Outsourcing of prison health care gets scrutiny; Alaska Native medical center seen as model

Eating raisins may provide the same workout boost as sports chews

Eating raisins may provide the same workout boost as sports chews

Bioniche receives U.S. and Canadian approval for first of two canine oncology products

Bioniche receives U.S. and Canadian approval for first of two canine oncology products

Scientists demonstrate link between cancer and faulty differentiation of stem cells

Scientists demonstrate link between cancer and faulty differentiation of stem cells

Recent release: Kaiser Health News interviews White House senior policy advisor ahead of AIDS 2012

Recent release: Kaiser Health News interviews White House senior policy advisor ahead of AIDS 2012

Forest Pharmaceuticals receives FDA approval for Tudorza Pressair to treat COPD

Forest Pharmaceuticals receives FDA approval for Tudorza Pressair to treat COPD

Recent release: Kaiser Family Foundation/Washington Post poll shows positive news about public opinion and HIV

Recent release: Kaiser Family Foundation/Washington Post poll shows positive news about public opinion and HIV

Working poor at heart of Medicaid expansion debate as governors draw line in the sand

Working poor at heart of Medicaid expansion debate as governors draw line in the sand

Neural precursor cells suppress aggressive tumors

Neural precursor cells suppress aggressive tumors

Synthetic triterpenoids block development of Parkinson's disease

Synthetic triterpenoids block development of Parkinson's disease

Views on AIDS:  Despite advances, still no cure, no vaccine, and indifference grows

Views on AIDS: Despite advances, still no cure, no vaccine, and indifference grows

Tiny microneedles to treat macular degeneration

Tiny microneedles to treat macular degeneration

Third-party groups to target health law with new wave of attack ads

Third-party groups to target health law with new wave of attack ads

HALO, UND enter agreement to develop biomarkers for early detection of breast cancer

HALO, UND enter agreement to develop biomarkers for early detection of breast cancer

Once-daily Gralise significantly reduces pain intensity in PHN patients

Once-daily Gralise significantly reduces pain intensity in PHN patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.